Clear The Air News Tobacco Blog Rotating Header Image

October, 2015:

Activists decry tobacco industry incentives

http://www.taipeitimes.com/News/taiwan/archives/2015/10/13/2003629941

DYING TRADE:A group called on the government to forbid the construction of any more tobacco factories and to close the industry to investment from overseas

Action should be taken to stop foreign firms investing in tobacco factories, activists said yesterday, condemning the Ministry of Economic Affairs for providing economic incentives even as tobacco production in other developed nations has fallen.

The Japan Tobacco International’s (JTI) investment in a new factory in the Tainan Technology Industrial Park comes as the “sun is setting” for the industry in Japan, John Tung Foundation chief executive officer Yao Shi-yuan (姚思遠) said, demanding that the government put the tobacco industry on a list of industries for which foreign investment is forbidden.

John Tung Foundation tobacco control division head Lin Ching-li (林清麗) said that four of Japan’s nine tobacco factories were scheduled to close by the end of the year, with an estimated 1,600 workers losing their jobs.

Because of the prohibitively high cost of producing cigarettes in Japan, the firms are being forced to move production overseas, Lin said.

The incentives the government provides for overseas investors — which include assistance acquiring land and exemptions from property and building taxes — are why Taiwan is seen as a base for expansion, she said.

The foundation called on the Executive Yuan to issue an order forbidding the construction of any more tobacco factories while also placing the industry on a list of industries closed to foreign investment.

It also called for the revocation of JTI’s construction license and the appropriation of Imperial Tobacco’s Miaoli factory, the only other foreign-owned tobacco factory in the nation.

INCREASING THE MINIMUM LEGAL SALE AGE FOR TOBACCO PRODUCTS TO 21

Download (PDF, 142KB)

Tobacco smoking and all-cause mortality in a large Australian cohort study

Download (PDF, 1.35MB)

Revealed: how ‘big tobacco’ used EU rules to win health delay

http://www.theguardian.com/business/2015/oct/11/tobacco-eu-delay

Cigarette companies pushed EC’s Better Regulation agenda to secure three-year moratorium on plain packaging

Marlboro Menthol cigarettes in new packaging in Australia. Photograph: Bloomberg/Bloomberg via Getty Images

Marlboro Menthol cigarettes in new packaging in Australia. Photograph: Bloomberg/Bloomberg via Getty Images

The world’s largest tobacco companies were instrumental in promoting Europe-wide, pro-business regulations that they used to delay health initiatives.

Analysis carried out by the University of Bath’s Tobacco Control Research Group (TCRG) has found that the companies played a key role in pushing the European commission’s Better Regulation agenda, which places business interests at the heart of policy drafting. They then used the new laws to block and delay a series of major health reforms, including UK introduction of plain packaging.

Under the terms of the Better Regulation agenda, which internal tobacco industry documents reveal was enthusiastically supported by British American Tobacco, European governments, including the UK, must conduct public consultations and impact assessments when introducing laws that affect business. The tobacco companies took advantage of these laws, using third parties and fake grassroots campaigns to swamp the consultations on anti-smoking initiatives such as the introduction of plain packaging. In addition, they were highly selective in what they submitted. All failed to include evidence – disclosed as a result of historic legal action – that they knew branded packaging was crucial to the marketing of their products, something they consistently denied in public.

For example, a document drawn up by Marlboro manufacturer Philip Morris in 1970 explained how pack recognition research was conducted by using hidden cameras on unsuspecting consumers in stores. It states: “As a prospective customer entered the area, he broke the photoelectric beam, immediately setting in motion the concealed camera which recorded the movement of his eyes and the final selection he made. From the thousands of films, the designers and advertising men were able to determine which package, which design and what combination of colours had the most appeal.”

 

Leaked documents show that Philip Morris identified the Better Regulation laws as a key weapon in its battle to derail the 2014 EU tobacco products directive which introduced large-scale health warnings on cigarette packets and a ban on flavoured cigarettes and packs of 10 –both popular marketing initiatives with young smokers. The tobacco giant employed more than 160 lobbyists and spent ¤1.25bn opposing the directive’s introduction. The European commission department responsible for drawing up the directive was swamped with 85,000 submissions. Many of the claims that they made were based on dubious evidence. According to the TCRG analysis of the submissions, “the research was of significantly lower quality than research supporting the measure. For example, the tobacco companies’ arguments were not supported by any peer-reviewed journal articles about standardised packaging.”

Nevertheless, the tobacco giants’ tactics resulted in a three-year delay in the introduction of plain packaging in the UK. Anna Gilmore, Professor of Public Health and Director of the TCRG, said their analysis highlighted the need for full transparency when it came to public consultations.

“The tobacco companies played a key role in implementing Better Regulation, anticipating that it would help them delay, block or weaken public health legislation,” Gilmore said.

“They have now gone on to exploit it to prevent life-saving regulations. They are flooding consultations with massive numbers of responses to give a totally misleading impression of opposition to public health policies. They then cite wholly misleading evidence that they have effectively manufactured to support their case.”

Cross-party parliamentary group calls for higher tobacco tax

http://www.digitallook.com/news/news-and-announcements–/cross-party-parliamentary-group-call-for-higher-tobacco-tax–891403.html

An increase in the tax on tobacco is needed to persuade more smokers to give up the habit, the All-Party Parliamentary Group on Smoking and Health has said.

At present, the tax rate is set at 2% above inflation each year, but the cross-party group of Peers and MPs is calling for that to be raised to 5%, which it believes would double the current rate of decline in smoking.

“Smokers don’t just die early, they suffer many years of disease and disability before they do, putting pressure not just on the NHS, but additional disability and social care costs and reduced income tax,” group chairman Bob Blackman, Conservative MP for Harrow East, said.

“Every pound invested over the next five years could deliver £11 to the public purse.”

The group anticipates that an additional £100m would be generated each year from the increased tax, which it said could be spent on anti-smoking schemes.

However, tobacco manufacturers have criticised the idea as being “counterproductive”.

The director general of the the Tobacco Manufacturers’ Association, Giles Roca, said: “Every time taxation is increased on tobacco it loses the Treasury millions that could have been spent on public services.”

He said this is because UK tobacco is the most expensive in Europe, with taxes increased by more than 40% during the past five years, which he said meant that smokers are “increasingly switching to cheaper and often illegal products, which loses the Treasury some £2.6bn each year”.

“Rather than imposing yet more tax on a legitimate UK sector, which directly and indirectly supports over 60,000 jobs and generates over £12bn in tax revenue, the UK government would be better served by holding an independent review of tobacco tax policy,” he said.

The Great Kentucky Hemp Experiment

http://www.newsweek.com/great-kentucky-hemp-experiment-381870

Western Kentucky University senior Corinn Sprigler helps harvest hemp plants at the WKU Farm in Bowling Green, Kentucky, in September 2014. Hemp potentially could be much more lucrative than tobacco if universities and farmers taking part in the Industrial Hemp Research Program, established by James Comer, Kentucky’s commissioner of agriculture, continue to hone their skills cultivating the crop. BAC TO TRONG/DAILY NEWS/AP

Western Kentucky University senior Corinn Sprigler helps harvest hemp plants at the WKU Farm in Bowling Green, Kentucky, in September 2014. Hemp potentially could be much more lucrative than tobacco if universities and farmers taking part in the Industrial Hemp Research Program, established by James Comer, Kentucky’s commissioner of agriculture, continue to hone their skills cultivating the crop. BAC TO TRONG/DAILY NEWS/AP

The Shell Farms & Greenhouses is an expansive 1,000-acre property in Garrard County, 37 miles south of Lexington, Kentucky. The five-generation family farm is operated by 31-year-old Giles Shell and his 60-year-old father, Gary. The two are whizzes at making ornamental flowers flourish, and like most farmers in the area, the family has grown tobacco for years.

In late June, the younger Shell stood outside one of six greenhouses on the farm and held up a yellowed tobacco plant with limp rootstock. The Shells know how to save sickly tobacco plants like this one, but they don’t want to anymore. “I’m hoping it’s our last crop,” Shell said.

Along the winding back roads of Central Kentucky’s bluegrass country, horses and cows graze on lush plains. For decades, tobacco helped farmers here keep their families clothed and fed. But that’s changing. Tobacco production facilities have slowly migrated to North Carolina, South Carolina and Tennessee due to consolidation within the industry, which has resulted in an ever-shrinking demand for the crop in Kentucky. There’s a replacement crop starting to come in, though: The Shell greenhouses that once nurtured thousands of tobacco plants are now home to 3,200 industrial hemp plants.

It’s been close to 70 years since anyone in Kentucky—or anywhere in the U.S.—attempted to legally cultivate industrial hemp in massive quantities. But today, the Shells and other skilled farmers are taking up the cash crop yet again, under the auspices of the five-year pilot Industrial Hemp Research Program, established by James Comer, Kentucky’s commissioner of agriculture, which vets and licenses farmers in the state.

Shifting gears so dramatically hasn’t been easy. The biggest problem is the learning curve: Hemp isn’t tobacco, which means it’s unlike the crop farmers in the area are most familiar with. A major component of the pilot project has involved figuring out the optimal way to make the plant flourish in a much rainier environment than California or Colorado, where most cannabis is currently grown. Farmers have experimented with a number of techniques: covering the beds to prevent over-watering (as you would, for example, with tomatoes) and growing cuttings in flower pots (as they do with ornamental flowers).

And there’s another undeniable challenge: Industrial hemp is really just a few genetic tweaks away from marijuana and outsiders often don’t know one from the other. “When the stuff really starts to flower it has the same look and smell as marijuana. That’s why we have security” to contend with potential plant thieves, says Shell.

The difference between the two cannabis sativa plants is the level of tetrahydrocannabinol (THC), the psychoactive chemical compound in the plant that’s responsible for causing the high. In order for cannabis to be considered industrial hemp, it must contain THC levels less than 0.3 percent; any more and the plant has officially crossed over into weed territory.

Currently all cannabis sativa—whether grown to ease chronic pain, get stoned or make rope—is a schedule I controlled substance, a result of the Controlled Substances Act passed by Congress in 1970, though state marijuana laws have changed some of the classifications at local levels. This is viewed as unfortunate by marijuana activists, but also by many in the agriculture industry, including Comer. He hopes to single-handedly turn industrial hemp into Kentucky’s No. 1 cash crop—and in the process, breathe new life into family farms that have lost millions of dollars with the fall of the tobacco industry.

Most industrial hemp is grown in China. With the right processing methods, the highly versatile plant can provide several notable revenue streams. Cannabidiol (CBD), a chemical compound in the plant, can be extracted from the leaves, blossoms and stems for medicinal and nutraceutical purposes. Cannabis oil derived from cold-pressing seeds is a healthful alternative to the oils sitting on most kitchen shelves, and it is already used in a number of cosmetic and beauty products. Other genetic variants of the plant are cultivated to produce fiber that can substitute for cotton, wood and plastic—a more sustainable way to make everyday products ranging from T-shirts to particleboard and even car dashboards.

And then there’s the potential for food. Hemp seed—high in fiber, antioxidants, omega-3s and protein—has a mild, nutty taste akin to flax. With the right marketing it could become the industry’s next superfood. It would also make for nutrient-packed animal feed.

Kentucky has a long, but mostly forgotten, history of hemp farming. The Speed family, intimately close friends of Abraham Lincoln, were hemp farmers in the state, as was Henry Clay, the 19th century statesman. Kentucky led the U.S. industrial hemp business until the end of the Civil War, when production of the crop declined and was generally replaced by tobacco. The Marihuana Tax Act of 1937 put the kibosh on all production and sales of cannabis, including industrial hemp, but the crop saw a rapid resurgence during World War II. Hemp fiber became essential to produce military necessities such as uniforms and parachutes. The U.S. Department of Agriculture launched its national “Hemp for Victory” program, which provided seeds and draft deferments to farmers. In 1942, farmers planted 36,000 acres of hemp seed. A USDA-funded informational film from that year noted that “hemp grows so luxuriantly in Kentucky that harvesting is sometimes difficult.”

With backing from Senator Rand Paul, Comer’s proposed legislation—Senate Bill 50—passed in 2013. It created a regulatory framework for farmers to legally grow hemp in the state. In addition, Paul and Comer were able to get a provision added to the federal Farm Bill that legalized hemp production in states like Kentucky that had programs set up to grow the crop. The bill was signed by President Obama in 2014.

Senator Rand Paul of Kentucky has backed the efforts of Comer to return hemp to its historical position as one of the Bluegrass State's cash crops. Its history in Kentucky includes even Abraham Lincoln, whose in-laws grew hemp, as well as Henry Clay, the 19th century statesman. Kentucky led the U.S. industrial hemp business until the end of the Civil War, when production of the crop declined and was replaced by tobacco. CARLOS BARRIA/REUTERS

Senator Rand Paul of Kentucky has backed the efforts of Comer to return hemp to its historical position as one of the Bluegrass State’s cash crops. Its history in Kentucky includes even Abraham Lincoln, whose in-laws grew hemp, as well as Henry Clay, the 19th century statesman. Kentucky led the U.S. industrial hemp business until the end of the Civil War, when production of the crop declined and was replaced by tobacco. CARLOS BARRIA/REUTERS

Though state and federal lawmakers support the efforts, Comer says it hasn’t been easy for Kentucky’s agriculture department or any of the farmers in the pilot program. Last year was the first for Kentucky’s pilot program, but it yielded only 33.4 acres of industrial hemp in the state. The farmers were capable of growing much more, but the U.S. Drug Enforcement Administration has made it challenging, says Comer. The DEA’s cannabis eradication program provides funding to local law enforcement to form a SWAT team of “cowboys flying around in helicopters.” They have been known to sweep through private farms to confiscate the plants, and have even been known to mistake okra for marijuana.

Despite all this, the project has nearly doubled its hemp production this year, and at least 500 people in the state are now employed at it as a result. Comer says he hopes farmers will soon be able to grow at least 10,000 acres. “We want to be the Silicon Valley for industrial hemp,” he says. The state’s backcountry has already become fertile ground for startups like GenCanna Global, which has partnered with six local farms to grow hemp for CBD.

Matty Mangone-Miranda, GenCanna’s president and chief executive officer, and Chris Stubbs, its chief scientific officer, conducted early work to cultivate low-THC, high-CBD cannabis plants formerly called “hippie’s disappointment”—since it doesn’t cause a high—and now known as Charlotte’s Web. It’s produced by the Realm of Caring Foundation as a dietary supplement under federal law and as medical cannabis for sale in states that allow for its use. The story of Charlotte’s Web first came to public light in 2013, when CNN aired Dr. Sanjay Gupta’s documentary Weed, featuring Charlotte Figi, a 5-year-old with a rare refractory epilepsy disorder known as Dravet syndrome that caused her to have up to 300 seizures per week. The Figis were preparing to sign “do not resuscitate” forms for their daughter when a friend connected them with the founders of the company, and the girl gained nearly complete seizure control once she started ingesting the CBD oil.

After the CNN documentary ran, Realm of Caring couldn’t keep up with the resulting high demand, says Mangone-Miranda. They still have thousands of families on their waiting list. “The lack of supply of oil was a huge problem,” he explains. “For me, the logical solution was that we needed a massive, sustainable and reliable supply.” To solve the problem, GenCanna has invested in Kentucky’s farms with the goal of planting 200,000 plants that are genetically similar to Charlotte’s Web in 2015.

Now, GenCanna has an increasing list of companies looking to purchase CBD oil to develop novel products that have absolutely nothing to do with treating rare seizure disorders or making healthy granola. The company has received proposals for CBD-infused sports drinks, wine, beer, Listerine-type fresh breath strips and transdermal patches.

Over the summer, GenCanna, along with Atalo Holdings—another hemp cooperative—purchased a 147-acre former tobacco seed development and breeding facility in Winchester, Kentucky. Along with storage, processing, formulating and shipping buildings, their new Hemp Research Campus includes an over-8,000-square-foot laboratory with breeding rooms. The two companies hope the Hemp Campus will serve as an incubator for the industry, says Steve Bevan, GenCanna’s chief operating officer. “With the Hemp Campus we think we can bring more and smarter people here,” he says. GenCanna and other companies hope to plant their flags before imminent changes in federal and state cannabis regulations allow Big Pharma to enter the picture. “They’re going to throw money in a big way, so we want to understand as much as possible because we have a belief that this stuff is food.”

There is currently a bill in U.S. Congress that would reclassify hemp from a narcotic to an agricultural crop. If the law were to pass, it would minimize the red tape for established hemp farming programs. For example, says Comer, “we won’t have to send staff to a field to do GPS coordinates and then get that information to the state police and all this bureaucracy.”

Despite the regulations and red tape, industrial hemp has already been a saving grace for some of the farmers in the pilot program. The Halverson family, for example, was preparing to shutter their operation, which primarily grew ornamental plants, until GenCanna approached them. The company offered to pay the rent for their property, cover all expenses upfront—including a refurbishing of the greenhouse—and provide salaries to the family and a staff of more than 20. One condition: They would turn all their energies to cultivating hemp and work with GenCanna to learn how to grow this complicated plant and find a way to breed the best version of the plant that is stronger and more aggressive.

Tobacco farmers only earn the equivalent of about 4 cents per pack of cigarettes. It’s still uncertain how much revenue hemp will bring into Kentucky's agriculture business but the farming community is hopeful. JESSICA FIRGER FOR NEWSWEEK

Tobacco farmers only earn the equivalent of about 4 cents per pack of cigarettes. It’s still uncertain how much revenue hemp will bring into Kentucky’s agriculture business but the farming community is hopeful. JESSICA FIRGER FOR NEWSWEEK

In the beginning, the Halversons were skeptical. The family are Sabbath-keeping Christians, and it was hard to know what their neighbors would think. But by that time the family had run out of money and options other than to close the farm. So they went for it.

At first, they were the subject of the weekly gossip at church. “You get to finishing some choral music, and then the conversation after is ‘Are you guys really growing that stuff?’” says Mikkel Halverson. “We feel that growing hemp is more than just work—it is a way we can help those in need. It is part of a healing ministry.” Now, the Halversons’ 36,000-square-foot greenhouse overflows with thousands of hemp plants.

Halverson knows he could probably make a lot more money if he grew the type of cannabis that gets people high, but his family has decided they will not grow a version of hemp that could potentially be smoked, no matter how skilled they become at farming the crop. “I think God made all of the plants,” he says. ”But we’re going to stick with CBD hemp.”

Brussels must resist lobbying by the tobacco industry

http://www.irishtimes.com/news/world/europe/brussels-must-resist-lobbying-by-the-tobacco-industry-1.2385730?mode=print&ot=example.AjaxPageLayout.ot

Emily O’Reilly

Lobbyists do a very straightforward job. They try to influence legislators to do things, or not to do things, that affect the bottom line of the people who pay them.

In 2012, the European Commission did something likely to affect the bottom line of the tobacco industry. It proposed a new Tobacco Products Directive aimed at reducing smoking rates across Europe, especially among young people.

And that was the starting pistol for hundreds of tobacco industry-hired lobbyists to fan out across Brussels and the member states, in a bid to curtail the potential commercial damage the new law could cause them worldwide.

Brussels is now a legislative powerhouse, and thus a hive of lobbying activity. Every morning, dozens queue for access passes in the European Parliament, while across the town, formal meetings fill diaries and countless informal meetings take place over coffee, lunch and dinner, as they seek a toehold on some part of the legislative ladder that will enable them to effect some change favourable to their clients.

Most of the biggest corporations in the world, from Google to British American Tobacco, to Shell and BP, have established a presence in the cobblestone streets around the EU quarter. With that has come an increasing stream of former EU officials going through the public service door and into a frequently lucrative private one. Highly prized insider intelligence and access is the currency that seeps through much of the legislative work of the EU.

By the time the Tobacco Products Directive finally passed into law two years later, the European Parliament, Commission and Council had been subjected to one of the most intense lobbying campaigns witnessed by the three institutions. It was, one commentator said, “the most lobbied dossier in the history of the EU institutions”.

And while the directive that emerged was generally well received as a significant contribution towards tobacco control and the safeguarding of public health, due to the hard work of many working on the issue, it was also clear that the lobbyists had won some victories along the way.

A softening of a plain packaging clause – meaning that it was left to member states to introduce such a measure if they chose – led to the current case taken by Japan Tobacco against the Irish Government’s decision to do just that.

The UK is being similarly sued by Philip Morris and British American Tobacco, and it in turn has brought a case to the ECJ to get clarity on certain aspects of the directive. Issues such as intellectual property and the right to free speech form part of the legal challenge.

The intent of the lobbyists was twofold. One, obviously, was to water down the original commission proposal, the other was to delay its passage to a point where perhaps a more favourable political climate might further dilute the bottom line impact of the proposed measures.

Now publicly available tobacco industry documents and evidence from MEPs and officials, testify to a massively well-funded and highly sophisticated campaign.

The approach was tailored, with bespoke approaches for individuals, institutions or ministers depending on cultural or political sensitivities and susceptibilities.

No argument was either too alarmist or too cynical to be discarded, whether wholesale unemployment of French tabac owners, or the cost to creaking health services of people actually living longer. The sophisticated use of “front groups” was another favourite tactic.

Strange things happened along the way, including the sudden and strange departure of the then EU health commissioner John Dalli. This threatened to derail the whole process ahead of the strongly anti-tobacco Irish presidency. Even stranger were break-ins to the Brussels offices of three anti-smoking NGOs which had material swiped from their databases.

As European Ombudsman, my involvement began when I received a series of complaints claiming that the European Commission had not been as transparent as it should be when it came to its dealings with tobacco lobbyists.

The complaints alleged that details of certain meetings had not been proactively published and that this was not in compliance with the 2003 UN Framework Convention on Tobacco Control, which the EU had signed up to in 2005. Indeed the commission itself played a leading role in pushing for this convention under then EU health commissioner David Byrne.

That convention is strikingly clear in its refusal to see the tobacco industry as a “normal” commercial interest to which “normal” rules of commercial engagement and commercial protection should apply.

Using highly-charged vocabulary, including the words “epidemic” and “devastating”, the industry is characterised as a pernicious one, severely damaging to global public health, and one to which as little quarter as possible should be given by governments and regulators.

Alongside other non-binding guidelines, the UN convention instructs all member states who signed up to it, and all EU institutions, to limit their interactions with the tobacco industry and to make any such interactions as transparent and as accountable as possible.

There is no doubt but that the commission was heavily lobbied and by extremely smart people – including lawyers – who used a belt and braces approach when it came to attempts to dissuade it from certain lines of action.

An examination of documents which outlined the industry approach showed that one tactic was to – in effect – shake the commission’s confidence when it came to the legality of certain crucial directive elements.

No institution relishes a trip to the courts to account for its work, and the lobbyists were well aware that this was a potentially fruitful tactic.

It would appear that, at the very least, it may have worked to slow down the passage of the directive.

My inquiry included an inspection of the commission’s files. We found that the Barroso Commission had not sought to conceal meetings, but that details of certain meetings were revealed only when an access, or FOI, request was made.

We further found that while the lead commission department, the directorate general for health, did proactively release details of all its contacts with the tobacco lobby, other directorates general did not.

The most interesting finding perhaps was that officials, when asked, revealed that they did not consider contacts with lawyers representing the industry to be meetings with lawyers acting potentially as lobbyists.

At the very least, this failure to see lawyers as potential lobbyists was naïve.

The most cursory examination of lobbying methodology, and particularly when it comes to regulatory affairs, shows how valuable lawyers are to the process.

Most websites of the more influential lobbying firms in Brussels demonstrate a proud – and far from hidden – showcasing of their hiring of former commission and other EU-insider lawyers, clearly valued for their knowledge of how the system works, and, no doubt, of how it can be tweaked in their new employer’s interests.

This so called “revolving door” phenomenon has been the basis of another ongoing inquiry by my office.

My recommendations to the commission, published earlier this week, are simple: that all of the directorates general should proactively release details of contacts with the tobacco industry, just as the directorate general health does, and should recognise lawyers as potential lobbyists and not as a separate caste.

It must be noted that the EU Commission in power since November 2014 under the presidency of Jean-Claude Juncker has made several positive steps towards more lobbying transparency. This is an example to other EU institutions, and indeed is now at a level of transparency better than most EU member states.

However the commission is the EU executive, it has great responsibilities and must lead by example.

To some observers, all of this might appear either abstract or high-minded. But recent revelations, for example, about Volkswagen’s deliberate concealment of the actual emission rates of their cars, shows the real-world cost of regulatory failure.

Over time, details may well emerge of how lobbyists for the car industry also worked to try to water down public-interest initiatives to safeguard the environment and public health.

How many more lives might be saved or public health further safeguarded if the Tobacco Directive had been even stricter, if clever lobbyists hadn’t been able to nibble around its edges?

The commission says that it believes it has been faithful to the UN convention and that in any event, the guidelines are not legally binding.

The former, in my view, is not the case, and the latter should not matter.

I do believe the commission has the best interests of citizens at heart and, while full of intelligent, hard-working people, I also believe it needs to engage those citizens more fully in its work by alerting them to the forces that seek to steer the commission in a direction in which perhaps it should not go.

The more transparency there is around lobbying, the more that an engaged civil society can work with dedicated public servants in the EU, to ensure that clever, well-resourced industry agents do not upset the balance between the safeguarding of a public interest and the right of an industry to safeguard its profits.

Emily O’Reilly is European Ombudsman

Hong Kong Customs seizes about 3.2 million sticks of suspected illicit cigarettes

http://7thspace.com/headlines/518296/hong_kong_customs_seizes_about_32_million_sticks_of_suspected_illicit_cigarettes.html

Hong Kong (HKSAR) – Hong Kong Customs detected a suspected smuggling case of illicit cigarettes yesterday (October 9) at Lok Ma Chau Control Point. About 3.2 million sticks of suspected illicit cigarettes were seized from an incoming lorry. The market value of the cigarettes was about $8.5 million with a duty potential of about $6 million.

Customs officers yesterday morning intercepted an incoming lorry declared to have 334 cartons of paper bags at Lok Ma Chau Control Point.

After thorough inspection, Customs officers found about 3.2 million sticks of suspected illicit cigarettes in another 244 carton boxes. The illicit cigarettes were mix-loaded with other goods and concealed in the rear part of the compartment. The 48-year-old male driver was arrested and the vehicle used for conveying the suspected illicit cigarettes was detained.

A Customs spokesman said, “The operation showed the effectiveness of the enforcement strategy, especially the escalated enforcement actions against smuggling activities at source.

Customs will continue to carry out stringent enforcement action against all illicit cigarette activities.”

Under the Import and Export Ordinance, smuggling is a serious offence. The maximum penalty is a fine of $2 million and imprisonment for seven years.

Members of the public are urged to report any suspected illicit cigarette activities to the Customs’ hotline at 2545 6182.

Tobacco Giants Say They Shouldn’t Be Singled Out under Trans-Pacific Partnership – Why Not When Their Products Kill 6 Million a Year

http://www.prnewswire.com/news-releases/tobacco-giants-say-they-shouldnt-be-singled-out-under-trans-pacific-partnership–why-not-when-their-products-kill-6-million-a-year-300157274.html

WASHINGTON, Oct. 9, 2015 /PRNewswire-USNewswire/ — The following is a statement of Matthew L. Myers, President, Campaign for Tobacco-Free Kids:

It is absurd that tobacco giants Philip Morris International and Altria are complaining the tobacco industry is being “singled out” because the new Trans-Pacific Partnership (TPP) trade agreement prevents them from using the TPP to attack life-saving measures to reduce tobacco use.

Tobacco products SHOULD be treated differently. They are uniquely lethal and kill when used as intended, and the tobacco industry is the poster child for abuse of the world trade system. How shameless of tobacco companies to play the victim when the real victims are the six million people their products kill worldwide each year.

It is not surprising for tobacco companies to say and do anything to sell more cigarettes despite the fact they kill millions every year. The question now is this: Will members of Congress stand for the right of governments, including our own government, to protect the health of their citizens from tobacco, or will they stand with the tobacco companies and help them spread death and disease around the world? Congress should reject the tobacco industry’s disingenuous arguments and support this landmark provision in the TPP that protects nations’ authority to enact tobacco control measures.

This safeguard for tobacco control measures is necessary given the abusive conduct of the tobacco industry and the uniquely harmful nature of tobacco products. Tobacco products are the only consumer products that kill when used as intended. Globally, tobacco is projected to kill one billion people this century unless governments implement effective tobacco control policies. There is a unique global consensus that nations must act as demonstrated by an international public health treaty, the World Health Organization Framework Convention on Tobacco Control, which has been ratified by 179 nations and the European Union.

The tobacco industry has fought back by filing – or threatening to file – costly trade lawsuits with the aim of defeating effective tobacco control measures or intimidating government into inaction. Australia and Uruguay are currently battling such lawsuits filed by Philip Morris International, and as reported by The New York Times, many other countries have been threatened with them. The huge costs of these lawsuits have discouraged nations from taking life-saving action.

In its statement on the TPP, Philip Morris International complains that these cases do not justify protecting tobacco control measures under the TPP and doing so would result in “a diminished rule of law.” In reality, it is Philip Morris’s own trade lawsuits that have diminished the rule of law and been viewed as so abusive that countries made it a priority to protect tobacco control measures under the TPP.

The tobacco industry and its political allies also claim this provision would harm tobacco farmers. Make no mistake: This provision would not impact trade of tobacco leaf in any way and includes language specifically exempting tobacco leaf. It is focused on preventing tobacco manufacturers’ abuse of the international trade system and addresses the actions of these manufacturers, not growers. Tobacco companies must not be allowed to hide behind tobacco growers to disguise their own wrongful behavior.

The tobacco industry’s abuse of trade agreements is a real and direct threat to public health around the world, and it must be stopped. It is the tobacco manufacturers’ own behavior that has created a broad consensus that they must not be allowed to threaten countries that act to protect their citizens from tobacco.

Big Tobacco’s Staunch Friend in Washington: U.S. Chamber of Commerce

Download (PDF, 548KB)